Histone deacetylase 6 is an enzyme that in humans is encoded by the HDAC6 gene.[5][6] HDAC6 has emerged as a highly promising candidate to selectively inhibit as a therapeutic strategy to combat several types of cancer and neurodegenerative disorders.[7]
Function
editHistones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromatin structure and affects transcription. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains that appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription.[8]
It retracts the cilium of the cell, which is necessary prior to mitosis. [9]
HDAC encourages cell motility and catalyzes α-tubulin deacetylation.[10] As a result the enzyme encourages cancer cell metastasis.[11]
HDAC6 affects transcription and translation by regulating heat-shock protein 90 (Hsp90).
HDAC6 is required in the formation of stress granule (SG) proteins and is instrumental in SG formation; pharmacological inhibition or genetic removal of HDAC6 abolished SG formation.[11]
HDAC6 bonds with high affinity to ubiquitinated proteins.[12]
Clinical relevance
editMutations in this gene have been associated to Alzheimer's disease.[15]
Over expression of this protein correlates with tumorigenesis and cell survival. HDAC6 also encourages metastasis of cancer cells.[11]
Since HDAC6 is dysregulated and/or implicated in several cancers and neurodegenerative disorders, pharmacological inhibition of this specific enzyme holds great therapeutic potential and could also limit side effects associated with pan-inhibitors of multiple HDAC enzymes.[7] Selective inhibition of HDAC6 as a strategy to treat cancers is however also subject of debate, since some HDAC6 inhibitors exhibited anti-tumor activity in vitro and in vivo only when administered in high concentrations, which also produced off-target effects. The findings suggest that further study is needed to clarify data on anti-cancer effects of selective HDAC6 inhibitors.[16]
Interactions
editHDAC6 has been shown to interact with HDAC11[17] and Zinc finger and BTB domain-containing protein 16.[18]
HDAC6 interacts with SG (Stress granule) protein G3BP1.[12]
See also
editReferences
edit- ^ a b c GRCh38: Ensembl release 89: ENSG00000094631 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000031161 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Grozinger CM, Hassig CA, Schreiber SL (April 1999). "Three proteins define a class of human histone deacetylases related to yeast Hda1p". Proceedings of the National Academy of Sciences of the United States of America. 96 (9): 4868–4873. Bibcode:1999PNAS...96.4868G. doi:10.1073/pnas.96.9.4868. PMC 21783. PMID 10220385.
- ^ Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, et al. (December 1998). "Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro". DNA Research. 5 (6): 355–364. doi:10.1093/dnares/5.6.355. PMID 10048485.
- ^ a b Geurs S, Clarisse D, Baele F, Franceus J, Desmet T, De Bosscher K, D'hooghe M (May 2022). "Identification of mercaptoacetamide-based HDAC6 inhibitors via a lean inhibitor strategy: screening, synthesis, and biological evaluation". Chemical Communications. 58 (42): 6239–6242. doi:10.1039/D2CC01550A. hdl:1854/LU-8752799. PMID 35510683. S2CID 248527466.
- ^ "Entrez Gene: HDAC6 histone deacetylase 6".
- ^ Krishnamurthy K, Wang G, Silva J, Condie BG, Bieberich E (February 2007). "Ceramide regulates atypical PKCzeta/lambda-mediated cell polarity in primitive ectoderm cells. A novel function of sphingolipids in morphogenesis". The Journal of Biological Chemistry. 282 (5): 3379–3390. doi:10.1074/jbc.M607779200. PMID 17105725.*Lay summary in: "Lipid helps cells find their way by keeping their 'antennae' up". phys.org/news. July 9, 2012.
- ^ Gao YS, Hubbert CC, Lu J, Lee YS, Lee JY, Yao TP (December 2007). "Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis". Molecular and Cellular Biology. 27 (24): 8637–8647. doi:10.1128/MCB.00393-07. PMC 2169396. PMID 17938201.
- ^ a b c Aldana-Masangkay GI, Sakamoto KM (2011). "The role of HDAC6 in cancer". Journal of Biomedicine & Biotechnology. 2011: 875824. doi:10.1155/2011/875824. PMC 2975074. PMID 21076528.
- ^ a b Kwon S, Zhang Y, Matthias P (December 2007). "The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response". Genes & Development. 21 (24): 3381–3394. doi:10.1101/gad.461107. PMC 2113037. PMID 18079183.
- ^ Lavars N (2022-01-18). "Targeting an enzyme in fat cells drives rapid weight loss in obese mice". New Atlas. Retrieved 2022-01-18.
- ^ Xu G, Niu L, Wang Y, Yang G, Zhu X, Yao Y, et al. (October 2022). "HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer". Cell Death & Disease. 13 (10): 888. doi:10.1038/s41419-022-05335-1. PMC 9587286. PMID 36270986.
- ^ Cook C, Gendron TF, Scheffel K, Carlomagno Y, Dunmore J, DeTure M, Petrucelli L (July 2012). "Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation". Human Molecular Genetics. 21 (13): 2936–2945. doi:10.1093/hmg/dds125. PMC 3373241. PMID 22492994.
- ^ Depetter Y, Geurs S, De Vreese R, Goethals S, Vandoorn E, Laevens A, et al. (August 2019). "Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models". International Journal of Cancer. 145 (3): 735–747. doi:10.1002/ijc.32169. PMID 30694564.
- ^ Gao L, Cueto MA, Asselbergs F, Atadja P (July 2002). "Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family". The Journal of Biological Chemistry. 277 (28): 25748–25755. doi:10.1074/jbc.M111871200. PMID 11948178.
- ^ Chauchereau A, Mathieu M, de Saintignon J, Ferreira R, Pritchard LL, Mishal Z, et al. (November 2004). "HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF". Oncogene. 23 (54): 8777–8784. doi:10.1038/sj.onc.1208128. PMID 15467736.
Further reading
edit- Pazin MJ, Kadonaga JT (May 1997). "What's up and down with histone deacetylation and transcription?". Cell. 89 (3): 325–328. doi:10.1016/S0092-8674(00)80211-1. PMID 9150131. S2CID 11488594.
- Wolffe AP (May 1997). "Transcriptional control. Sinful repression". Nature. 387 (6628): 16–17. doi:10.1038/387016a0. PMID 9139815. S2CID 29803420.
- Huynh KD, Fischle W, Verdin E, Bardwell VJ (July 2000). "BCoR, a novel corepressor involved in BCL-6 repression". Genes & Development. 14 (14): 1810–1823. doi:10.1101/gad.14.14.1810. PMC 316791. PMID 10898795.
- Mahlknecht U, Schnittger S, Landgraf F, Schoch C, Ottmann OG, Hiddemann W, Hoelzer D (2001). "Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosome p11.23 by in situ hybridization". Cytogenetics and Cell Genetics. 93 (1–2): 135–136. doi:10.1159/000056967. PMID 11474198. S2CID 41821644.
- Kao HY, Lee CH, Komarov A, Han CC, Evans RM (January 2002). "Isolation and characterization of mammalian HDAC10, a novel histone deacetylase". The Journal of Biological Chemistry. 277 (1): 187–193. doi:10.1074/jbc.M108931200. PMID 11677242.
- Seigneurin-Berny D, Verdel A, Curtet S, Lemercier C, Garin J, Rousseaux S, Khochbin S (December 2001). "Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways". Molecular and Cellular Biology. 21 (23): 8035–8044. doi:10.1128/MCB.21.23.8035-8044.2001. PMC 99970. PMID 11689694.
- Tong JJ, Liu J, Bertos NR, Yang XJ (March 2002). "Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain". Nucleic Acids Research. 30 (5): 1114–1123. doi:10.1093/nar/30.5.1114. PMC 101247. PMID 11861901.
- Gao L, Cueto MA, Asselbergs F, Atadja P (July 2002). "Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family". The Journal of Biological Chemistry. 277 (28): 25748–25755. doi:10.1074/jbc.M111871200. PMID 11948178.
- Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al. (May 2002). "HDAC6 is a microtubule-associated deacetylase". Nature. 417 (6887): 455–458. Bibcode:2002Natur.417..455H. doi:10.1038/417455a. PMID 12024216. S2CID 4373254.
- Kirsh O, Seeler JS, Pichler A, Gast A, Müller S, Miska E, et al. (June 2002). "The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase". The EMBO Journal. 21 (11): 2682–2691. doi:10.1093/emboj/21.11.2682. PMC 125385. PMID 12032081.
- Hook SS, Orian A, Cowley SM, Eisenman RN (October 2002). "Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes". Proceedings of the National Academy of Sciences of the United States of America. 99 (21): 13425–13430. Bibcode:2002PNAS...9913425H. doi:10.1073/pnas.172511699. PMC 129689. PMID 12354939.
- Westendorf JJ, Zaidi SK, Cascino JE, Kahler R, van Wijnen AJ, Lian JB, et al. (November 2002). "Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter". Molecular and Cellular Biology. 22 (22): 7982–7992. doi:10.1128/MCB.22.22.7982-7992.2002. PMC 134736. PMID 12391164.
- North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (February 2003). "The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase". Molecular Cell. 11 (2): 437–444. doi:10.1016/S1097-2765(03)00038-8. PMID 12620231.
- Voelter-Mahlknecht S, Mahlknecht U (July 2003). "Cloning and structural characterization of the human histone deacetylase 6 gene". International Journal of Molecular Medicine. 12 (1): 87–93. doi:10.3892/ijmm.12.1.87. PMID 12792815.
- Brush MH, Guardiola A, Connor JH, Yao TP, Shenolikar S (February 2004). "Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases". The Journal of Biological Chemistry. 279 (9): 7685–7691. doi:10.1074/jbc.M310997200. PMID 14670976.
- Pandey UB, Batlevi Y, Baehrecke EH, Taylor JP (Nov–Dec 2007). "HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration". Autophagy. 3 (6): 643–645. doi:10.4161/auto.5050. PMID 17912024.
- Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, et al. (June 2007). "HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS". Nature. 447 (7146): 859–863. Bibcode:2007Natur.447..860P. doi:10.1038/nature05853. PMID 17568747. S2CID 4365061.
External links
edit- HDAC6+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- HDAC6 human gene location in the UCSC Genome Browser.
- HDAC6 human gene details in the UCSC Genome Browser.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.